Publication: Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy
No Thumbnail Available
STENZEL, Martina H.
Fructose transporter GLUT5 is overexpressed in breast cancer cell lines, but not in healthy tissue. Micelles based on fructose, which were found to be low fouling, showed a high uptake by breast cancer cells (MCF-7 and MDA-MB-231 cells), but only negligible uptake by macrophages.
ZHAO J., BABIUCH K., Lu H., Dag A., GOTTSCHALDT M., STENZEL M. H. , -Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy-, CHEMICAL COMMUNICATIONS, cilt.50, ss.15928-15931, 2014